We have entered a new era where an Artificially Intelligent (AI) Laboratory today is becoming more science, than science fiction. There is a paradigm shift going on with the outdated pharmaceutical R&D blockbuster drug model which takes 10 years at a cost of up to €2.6 billion to bring a single drug to market. Big data analytics is key to transforming the future of skin disease drug development.
Skin disease is ranked as the fourth most common cause of human illness. While drug companies still chase molecules for new blockbuster drugs, millions of people are suffering from skin related diseases today. Wouldn’t it be better to find a solution that improves existing products, transforms them to deliver superior skin healing capabilities, all certified by extensive real-world, real-time, laboratory testing?
By introducing AI into a laboratory setting with an already successful business model, you take what already exists, what already works and may well have been built for another purpose, and you refine and improve it to deliver more from the same technology. It is not necessary to invent or recreate anything.
By Deepverge – October 15th, 2019
There will be two separate devices: an environmental sensor and a biomarker sensor. COPD- and…
Our team has a lot to share about South Asian markets! Key figures, key facts…
Celebrity hairdresser brands are making waves and are especially popular among young Europeans. As a…